申请人:Sunovion Pharmaceuticals Inc.
公开号:US20180028492A1
公开(公告)日:2018-02-01
Compounds of formula I:
are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric diseases and disorders in a subject in need thereof are also disclosed.